MIRAPEX

LOE Approaching

pramipexole dihydrochloride

NDAORALTABLET
Approved
Jul 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
9

Clinical Trials (5)

NCT01525641N/ACompleted

Safety and Efficacy of Long-term Daily Use of Mirapex®-LA Tablets in Patients With Parkinson's Disease

Started Feb 2012
615 enrolled
Parkinson Disease
NCT00893841Phase 2Completed

Bipolar Study of Seroquel XR With Pramipexole Dihydrochloride

Started Feb 2009
96 enrolled
Bipolar Depression
NCT01100073N/ACompleted

Kinetic Tremor in Parkinsons Disease: Its Course Under Pramipexole (Mirapexin®) Treatment and Impact on Quality of Life

Started Feb 2008
1,703 enrolled
Parkinson Disease
NCT01170091N/ACompleted

Safety and Effect of Mirapex(Pramipexole) Tablet Among Korean RLS

Started Dec 2007
651 enrolled
Restless Legs Syndrome
NCT00375284Phase 4Completed

A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS

Started Sep 2006
404 enrolled
Restless Legs Syndrome